Co-Founding CEO – Metabolic & Inflammation Therapies

Posted 4ds ago

Employment Information

Industry
Education
Salary
Experience
Job Type

Report this job

Job expired or something wrong with this job?

Job Description

Co-founding CEO leading strategy, fundraising, and team building for NLC’s first-in-class metabolic disease biotech venture. Advancing INT-101 from preclinical development toward clinical trials.

Responsibilities:

  • Define and execute the company's strategy, aligning science, operations, and business goals
  • Lead seed and Series A fundraising, leveraging networks and partnerships to secure capital and strategic collaborations
  • Choose and prioritize indication strategy, such as DKD, obesity, atherosclerosis, or MASH, based on opportunity, patient need, and risk
  • Oversee the transition from preclinical development to IND submission and clinical development
  • Build and manage the team as the company progresses
  • Collaborate with Professor Ann Marie Schmidt and advisors to integrate scientific excellence with commercial strategy
  • Represent the venture to investors, partners, and the scientific community
  • Lead all aspects of the venture's growth from strategy-setting through advancing programs into clinical trials

Requirements:

  • Proven biotech or life sciences leader with early-stage venture experience
  • Successful fundraising track record
  • Strong scientific and strategic understanding of metabolic diseases, such as diabetes, kidney disease, or obesity, or related areas
  • Experience guiding programs through preclinical and regulatory development toward the clinic
  • Ability to turn complex science into a clear, fundable business plan
  • Exceptional communication and relationship-building skills with investors, advisors, and diverse stakeholders
  • Hands-on, adaptable leadership suited to dynamic startup environments
  • Integrity, credibility, and a collaborative mindset
  • ASAP preferred, with Q4 2026 at the latest start date

Benefits:

  • Equity-only compensation, transitioning to salary after fundraising
  • Part-time commitment to start, with greater time commitment expected as the company scales